An Open-Label, Multicenter, Extension Study for Subjects Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

Conditions:   Acute Myeloid Leukemia;   Chronic Myelomonocytic Leukemia;   Myelodysplastic Syndromes Intervention:   Drug: ASTX727 Sponsor:   Astex Pharmaceuticals, Inc. Not yet recruiting

Source: ClinicalTrials.gov - September 18, 2019 Category: Research Source Type: clinical trials